RxDoctor Payments Data

Kenzi Holden, PA

Physician Assistant · Springfield, MANPI 1952718678

Payments from drug & device makers

$200in general payments, 2019–2025

Across 11 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$33
  • GSK$30
  • Tandem Diabetes Care, Inc.$27
  • Mallinckrodt Hospital Products Inc.$24
  • Sun Pharmaceutical Industries Inc.$21
  • Boehringer Ingelheim$20
  • plus $44 from 3 others

What the payments were for

  • Food & beverage$200100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$200 in reported general payments places this provider in the 70th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$25,121
Medicare patients
115
Services billed
374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide97$104,226
TrulicityDulaglutide81$86,461
MounjaroTirzepatide69$73,285
JardianceEmpagliflozin29$36,305
EliquisApixaban14$19,559
Tresiba Flextouch U-200Insulin Degludec14$11,827
Tresiba Flextouch U-100Insulin Degludec18$10,070
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,985
Novolog FlexpenInsulin Aspart24$5,163
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$4,427
Humalog Kwikpen U-100Insulin Lispro16$2,678
Atorvastatin Calcium122$2,207
Gabapentin73$1,376
Lisinopril128$1,123
Diclofenac Sodium24$985

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$104,22697 claims
Boehringer IngelheimJardiance$20$36,30529 claims
GSKAnoro Ellipta$30$5,98512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,507 physician assistant providers in Massachusetts.

Other physician assistant in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →